MedTrace Logo

DEB for Symptomatic Intracranial Atherosclerosis Stenosis

NCT04821726 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2023-01-31

No results posted yet for this study

Summary

A prospective, multi-center, single-arm study to evaluate the safety and efficacy of drug eluting balloon catheter for the treatment of patients with symptomatic intracranial atherosclerotic stenosis.

Conditions

  • Cerebral Ischemia
  • Cerebral Atherosclerosis

Interventions

DEVICE

Drug eluting balloon (Vmoky)

Use Vmoky Drug Eluting Balloon to treat patients with symptomatic intracranial atherosclerosis stenosis

Sponsors & Collaborators

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Yinyi(Liaoning) Biotech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Tianxiao Li · Henan Provincial People's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2023-08-30
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821726 on ClinicalTrials.gov